Data / Form D filings / D&D Pharmatech Inc.
D&D Pharmatech Inc.: Form D filing
D&D Pharmatech Inc., a pharmaceuticals company in Seongnam-Si, Korea, Republic Of, filed a Form D with the SEC in 2025. The latest, on August 1, 2025, reports $10.8 million sold of a $10.8 million offering to 8 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 4TH FLOOR, 27, GEUMTO-RO 80BEON-GIL, SUJEONG-GU, Seongnam-Si, Korea, Republic Of, 13454
- Phone
- 82-31-8019-7771
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Korea, Republic Of
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2077939
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 1, 2025 | New notice | $10,800,000 | $10,800,000 | 8 | Jun 20, 2025 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Seulki Lee | Executive Officer, Director | |
| Sungmook Lim | Executive Officer, Director | |
| Daehyun Shin | Director | |
| Seol-Heui Han | Director | |
| Seungwon Lim | Director | |
| Sunghoon Hong | Executive Officer, Director |
Every Form D from the week of Jul 28, 2025 · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what D&D Pharmatech Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.